We found that GCS protein level and enzyme activity in MCF- 7/Dox breast cancer cells (MCF-7/Dox) were 2 times higher than these in bone marrow cells; Dox treatments (0.5 μM) significantly increased GCS expression in cancer cells, rather than in bone marrow cells [1]. This evidence concerns the gene UGCG and cancer.